Search

everythinglearnresearchcommunity

for

Search:↓

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Blocking a protein called prostaglandin D2 might help treat hair loss.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

A new compound may treat benign prostatic hyperplasia better than finasteride.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

New progesterone-based compounds can block male hormones.

New compounds similar to cromakalim were less effective at inhibiting insulin release but improved in solubility and one acted as a calcium entry blocker, not a potassium channel opener.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Combination drug therapies are more effective for high-risk BPS patients but have more side effects and costs.

Topical calcitriol was safe and well-tolerated for potential hair loss prevention in chemotherapy patients.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Primary hypothyroidism can mimic pituitary failure but improves with hormone therapy.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Cryptotanshinone may help treat postmenopausal osteoporosis and protect kidneys.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Diet can prevent bone issues but not hair loss in mice lacking vitamin D receptors.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.